Wealthfront Advisers LLC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Wealthfront Advisers LLC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$256,594
-61.7%
6,799
-53.8%
0.00%
-66.7%
Q2 2023$670,005
+45.1%
14,706
+29.2%
0.00%
+50.0%
Q1 2023$461,735
+6.2%
11,384
+33.5%
0.00%0.0%
Q4 2022$434,723
-86.2%
8,529
-85.4%
0.00%
-88.2%
Q3 2022$3,151,000
-18.7%
58,496
-3.0%
0.02%
-10.5%
Q2 2022$3,874,000
+22.2%
60,314
+47.6%
0.02%
+35.7%
Q1 2022$3,169,000
-28.0%
40,863
-20.3%
0.01%
-26.3%
Q4 2021$4,400,000
+33.2%
51,263
+24.8%
0.02%
+26.7%
Q3 2021$3,304,000
+59.5%
41,074
+59.6%
0.02%
+50.0%
Q2 2021$2,072,000
+47.1%
25,739
+54.1%
0.01%
+25.0%
Q1 2021$1,409,000
+15.3%
16,704
+9.7%
0.01%
+14.3%
Q4 2020$1,222,000
+4.4%
15,227
+4.7%
0.01%
-12.5%
Q3 2020$1,170,000
-3.5%
14,549
+3.4%
0.01%
-11.1%
Q2 2020$1,212,000
+2.0%
14,075
-3.8%
0.01%
-18.2%
Q1 2020$1,188,000
-14.1%
14,634
-11.5%
0.01%
+10.0%
Q4 2019$1,383,000
+17.0%
16,535
+22.4%
0.01%0.0%
Q3 2019$1,182,000
+7.6%
13,511
+0.7%
0.01%0.0%
Q2 2019$1,099,000
-0.7%
13,421
-1.4%
0.01%0.0%
Q1 2019$1,107,000
+37.2%
13,614
+11.0%
0.01%
+11.1%
Q4 2018$807,00012,2670.01%
Other shareholders
BAXTER INTL INC shareholders Q1 2022
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders